Alzheimer’s & Dementia researchers challenge FDA’s approval of Aduhelm given lack of evidence for beta-amyloid as a marker

Doc­tors Blast Bio­gen Alzheimer Approval as ‘Reg­u­la­to­ry Fail­ure’ (Bloomberg): Top researchers who advised the U.S. Food and Drug Admin­is­tra­tion on Bio­gen Inc.’s Alzheimer’s drug blast­ed the agency for approv­ing it, call­ing the deci­sion a “reg­u­la­to­ry fail­ure” that is “at odds with the evidence.”

Read More

Debate: What is the role of financial advisors and platforms in detecting and addressing cognitive decline among older clients?

Baby Boomers’ Biggest Finan­cial Risk: Cog­ni­tive Decline (The Wall Street Jour­nal): For baby boomers who man­age their own nest eggs, a risk is loom­ing that has noth­ing to do with stock prices or inter­est rates. The risk is cog­ni­tive decline, which can rob them of their judg­ment, often with­out much warn­ing. One big mistake—or a series…

Read More

On building better brains at any age, treating Depression vs. Dementia, emerging neurotechnologies, psychedelics, and more

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing eleven new research find­ings and inno­v­a­tive resources for life­long cog­ni­tive and brain health. #1. Debate: Are depres­sion and demen­tia two sides of the same coin? And, if they are, how to best approach treat­ment? #2. Either way, the ear­li­er the bet­ter, but it’s nev­er too late: New…

Read More

Next in NASA’s path to Mars: Overcoming astronauts’ cognitive and mental health challenges

Space Between the Ears (Cere­brum): A few short months ago, news pro­grams around the globe showed NASA engi­neers and sci­en­tists cel­e­brat­ing as a robot named Per­se­ver­ance suc­cess­ful­ly land­ed on the sur­face of Mars. The mis­sion: cap­ture and share images and audio that have nev­er been seen or heard before. As impressed as most observers were…

Read More